Progress-PME is official programme sponsor
On the 26th of November 2020 Progress-PME will attend the Dutch Life Science Conference 2020 as official programme sponsor. We would be delighted to meet you at our stand. Click on the link below to find out more about the Dutch Life Science Conference and to take advantage of the early-bird special.
On the day of the conference, at 11:15 hours, our managing consultant Frank van Engelenburg will be hosting a session on Advanced cell and gene-based therapeutics. More details will follow soon.
Frank is an experienced CMC Leader; he has successfully led multiple CMC projects ranging from early development projects to late-stage development and for MAA/BLA of monoclonal antibodies, vaccines and gene therapy products. In this role, he has been responsible for meeting quality aspects of different biologics, CMC development strategy, CMC regulatory strategy, and for CMC planning and budget control.
He has a broad knowledge of regulatory laws and guidance for biologics and ample experience in writing CMC statutory documentation, including for IMPD/IND and MAA/BLA. Frank has represented the CMC function in several regulatory meetings with EMA, FDA, and PMDA. Frank holds a PhD in virology and is an expert of viral and prion safety of biologics. He has in-depth expertise in molecular biology, virology, and vaccine development.